Explore the legal risks and FDA rules surrounding false advertising in generic pharmaceuticals, including the 2025 regulatory crackdown and Lanham Act liabilities.
Read More
The FDA is cracking down on non-compliant manufacturers with stricter warning letters, unannounced inspections, and criminal penalties. Learn how the agency enforces safety standards-and what happens if you ignore them.
Read More© 2026. All rights reserved.